Cecilia Arana Yi, MD. MSHS, FACP

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Autolus
    Topic:
    Advisory Board
    Date added:
    12/02/2024
    Date updated:
    01/11/2025
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Blueprint Medicines
    Topic:
    Advisory Board
    Date added:
    01/11/2025
    Date updated:
    01/11/2025
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Cogent Biosciences
    Topic:
    Advisory Board
    Date added:
    01/11/2025
    Date updated:
    01/11/2025
  • Attribution:
    Self
    Type of financial relationship:
    Travel
    Ineligible company:
    DAVA oncology
    Topic:
    Travel Grant
    Date added:
    01/11/2025
    Date updated:
    01/11/2025
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Blueprint Medicines
    Topic:
    Research Funding
    Date added:
    01/11/2025
    Date updated:
    01/11/2025
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Blueprint Medicines
    Topic:
    other
    Date added:
    01/11/2025
    Date updated:
    01/11/2025
Return to Best of Hematology and Breast Cancer 2025, Tucson